Research
37 podcasts
Top Research Presented at the 2021 San Antonio Breast Cancer Symposium
Sara Tolaney, MD, MPHDecember 21, 2021 · 10:00Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease
Jeremy Braybrooke, BSc, BM, FRCP, PhD, Rosie Bradley, MSc, BScDecember 13, 2021 · 14:19Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?
Aditya Bardia, MD, MPHDecember 11, 2021 · 12:58Breast Cancer Research at ESMO 2021
Brian Wojciechowski, MDOctober 21, 2021 · 14:09Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer
Gabriel N. Hortobagyi, MD, FACPOctober 1, 2021 · 19:47Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer
Hope S. Rugo, MDSeptember 24, 2021 · 25:03Showing 6 of 37